title: Non-small-cell lung cancer patients unsuitable for first-line chemotherapy: a new category of patients for clinical studies?
authors.forename: Héctor J
authors.initials: HJ
authors.lastname: Soto Parra
authors.forename: Fiorenza
authors.initials: F
authors.lastname: Latteri
authors.forename: Raffaele
authors.initials: R
authors.lastname: Cavina
authors.forename: Fabio
authors.initials: F
authors.lastname: De Vincenzo
authors.forename: Paolo A
authors.initials: PA
authors.lastname: Zucali
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Campagnoli
authors.forename: Armando
authors.initials: A
authors.lastname: Santoro
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D018579:Patient Selection; D011799:Quinazolines / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib